Patents by Inventor Samirkumar Rajnikant Patel
Samirkumar Rajnikant Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210393436Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: ApplicationFiled: January 4, 2021Publication date: December 23, 2021Inventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Patent number: 10905586Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: GrantFiled: March 23, 2020Date of Patent: February 2, 2021Assignees: Georgia Tech Research Corporation, Emory UniversityInventors: Mark Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Publication number: 20210022918Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: ApplicationFiled: October 2, 2020Publication date: January 28, 2021Inventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Publication number: 20200237556Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: ApplicationFiled: March 23, 2020Publication date: July 30, 2020Inventors: Mark Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Patent number: 10632013Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: GrantFiled: September 19, 2017Date of Patent: April 28, 2020Assignees: GEORGIA TECH RESEARCH CORPORATION, EMORY UNIVERSITYInventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Publication number: 20180028357Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: ApplicationFiled: September 19, 2017Publication date: February 1, 2018Inventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Patent number: 9788995Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: GrantFiled: December 20, 2013Date of Patent: October 17, 2017Assignees: Georgia Tech Research Corporation, Emory UniversityInventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Patent number: 8808225Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: GrantFiled: April 15, 2012Date of Patent: August 19, 2014Assignees: Emory University, Georgia Tech Research CorporationInventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Publication number: 20140107566Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: ApplicationFiled: December 20, 2013Publication date: April 17, 2014Applicants: Georgia Tech Research Corporation, Emory UniveristyInventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Patent number: 8636713Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: GrantFiled: April 23, 2012Date of Patent: January 28, 2014Assignees: Emory University, Georgia Tech Research CorporationInventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Publication number: 20120232522Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: ApplicationFiled: April 23, 2012Publication date: September 13, 2012Inventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Publication number: 20120226260Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: ApplicationFiled: April 15, 2012Publication date: September 6, 2012Applicants: Georgia Tech Research Corporation, Emory UniversityInventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Patent number: 8197435Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: GrantFiled: April 26, 2010Date of Patent: June 12, 2012Assignees: Emory University, Georgia Tech Research CorporationInventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel
-
Publication number: 20100256597Abstract: Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.Type: ApplicationFiled: April 26, 2010Publication date: October 7, 2010Applicants: EMORY UNIVERSITY, GEORGIA TECH RESEARCH CORPORATIONInventors: Mark R. Prausnitz, Henry F. Edelhauser, Samirkumar Rajnikant Patel